• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Hydroxychloroquine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The global hydroxychloroquine market witnessed strong growth during 2014-2019. Hydroxychloroquine (HCQ), with the chemical formula C18H26ClN3O, is a chemotherapeutic agent drug that is primarily used for the prevention and treatment of malaria. It acts against erythrocytic forms of malarial parasites and is majorly administered in the form of an oral tablet. It is also used for the treatment of various other diseases, such as systemic lupus erythematosus, rheumatoid arthritis, Q fever and Porphyria Cutanea Tarda (PCT) and is being examined for the possible treatment of the rapidly spreading COVID-19 disease. It exhibits immunosuppressive, anti-autophagy and antimalarial properties as it suppresses immune functions and presents antigens and cytokines in the body. 

The sudden outbreak of the COVID-19 pandemic across the globe is one of the key factors driving the growth of the market. Various clinical trials and experiments are being conducted across the globe to analyze the efficacy and safety of hydroxychloroquine for the treatment of adults hospitalized with the coronavirus disease. The increasing prevalence of malaria and various other chronic diseases, especially in developing and underdeveloped countries, is also leading to the widespread adoption of this drug. In line with this, the rapidly rising cases of autoimmune diseases, such as lupus erythematosus and rheumatoid arthritis, are acting as another growth-inducing factor. Other factors, including the implementation of favorable government policies to promote global health, along with extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further. Looking forward, IMARC Group expects the global hydroxychloroquine market to experience robust growth during the next five years.

Breakup by Dosage Type:

  • 200 Mg
  • 300 Mg
  • 400 Mg
  • Others
     

Breakup by Distribution:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
     

Breakup by Application:

  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Malaria
  • Coronavirus (COVID-19)
  • Others
     

Breakup by Grade:

  • USP Standards Grade
  • EP Standards Grade
  • Pharmaceutical Standards Grade
  • Others
     

Breakup by Route of Administration:

  • Oral
  • Intravenous
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Amneal Pharmaceuticals Inc., Cardinal Health Inc., Cipla Ltd., Ipca Laboratories Ltd., Laurus Labs, Lupin Limited, Mylan N.V., Novartis AG, Prasco Laboratories, Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharma, Zydus Cadila, etc.

Key Questions Answered in This Report:

  • How has the global hydroxychloroquine market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global hydroxychloroquine market?
  • What is the breakup of the market based on the dosage type?
  • What is the breakup of the market based on the distribution?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the grade?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hydroxychloroquine market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Hydroxychloroquine Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Dosage Type
    6.1    200 Mg
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    300 Mg
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    400 Mg
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Distribution
    7.1    Hospital Pharmacies
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Retail Pharmacies
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Application
    8.1    Rheumatoid Arthritis
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Lupus Erythematosus
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Malaria
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Coronavirus (COVID-19)
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Grade
    9.1    USP Standards Grade
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    EP Standards Grade
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Pharmaceutical Standards Grade
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Route of Administration
    10.1    Oral
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Intravenous
        10.2.1 Market Trends
        10.2.2 Market Forecast
11    Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12    SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15    Price Indicators
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Amneal Pharmaceuticals Inc.
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio 
           16.3.1.3 Financials 
        16.3.2    Cardinal Health Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials 
           16.3.2.4 SWOT Analysis
        16.3.3    Cipla Ltd.
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
        16.3.4    Ipca Laboratories Ltd.
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
        16.3.5    Laurus Labs
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio 
           16.3.5.3 Financials 
        16.3.6    Lupin Limited
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
           16.3.6.3 Financials  
           16.3.6.4 SWOT Analysis
        16.3.7    Mylan N.V.
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 Financials 
           16.3.7.4 SWOT Analysis
        16.3.8    Novartis AG
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio 
           16.3.8.3 Financials 
           16.3.8.4 SWOT Analysis
        16.3.9    Prasco Laboratories
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
        16.3.10    Dr. Reddy’s Laboratories Ltd.
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio 
           16.3.10.3 Financials 
           16.3.10.4 SWOT Analysis
        16.3.11    Sanofi S.A.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio 
           16.3.11.3 Financials 
           16.3.11.4 SWOT Analysis
        16.3.12    Teva Pharmaceutical Industries Ltd.
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio 
           16.3.12.3 Financials 
           16.3.12.4 SWOT Analysis
        16.3.13    Torrent Pharma
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio 
        16.3.14    Zydus Cadila
           16.3.14.1 Company Overview
           16.3.14.2 Product Portfolio 

List of Figures

Figure 1: Global: Hydroxychloroquine Market: Major Drivers and Challenges
Figure 2: Global: Hydroxychloroquine Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Hydroxychloroquine Market: Breakup by Dosage Type (in %), 2019
Figure 4: Global: Hydroxychloroquine Market: Breakup by Distribution (in %), 2019
Figure 5: Global: Hydroxychloroquine Market: Breakup by Application (in %), 2019
Figure 6: Global: Hydroxychloroquine Market: Breakup by Grade (in %), 2019
Figure 7: Global: Hydroxychloroquine Market: Breakup by Route of Administration (in %), 2019
Figure 8: Global: Hydroxychloroquine Market: Breakup by Region (in %), 2019
Figure 9: Global: Hydroxychloroquine Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 10: Global: Hydroxychloroquine (200 Mg) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Hydroxychloroquine (200 Mg) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Hydroxychloroquine (300 Mg) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Hydroxychloroquine (300 Mg) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Hydroxychloroquine (400 Mg) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Hydroxychloroquine (400 Mg) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Hydroxychloroquine (Other Dosage Types) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Hydroxychloroquine (Other Dosage Types) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Hydroxychloroquine (Hospital Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Hydroxychloroquine (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Hydroxychloroquine (Retail Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Hydroxychloroquine (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Hydroxychloroquine (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Hydroxychloroquine (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Hydroxychloroquine (Rheumatoid Arthritis) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Hydroxychloroquine (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: Global: Hydroxychloroquine (Lupus Erythematosus) Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: Global: Hydroxychloroquine (Lupus Erythematosus) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: Global: Hydroxychloroquine (Malaria) Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: Global: Hydroxychloroquine (Malaria) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: Global: Hydroxychloroquine (Coronavirus- COVID-19) Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: Global: Hydroxychloroquine (Coronavirus- COVID-19) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: Global: Hydroxychloroquine (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: Global: Hydroxychloroquine (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: Global: Hydroxychloroquine (USP Standards Grade) Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: Global: Hydroxychloroquine (USP Standards Grade) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Global: Hydroxychloroquine (EP Standards Grade) Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Global: Hydroxychloroquine (EP Standards Grade) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: Global: Hydroxychloroquine (Pharmaceutical Standards Grade) Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: Global: Hydroxychloroquine (Pharmaceutical Standards Grade) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: Global: Hydroxychloroquine (Other Standards Grades) Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: Global: Hydroxychloroquine (Other Standards Grades) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: Global: Hydroxychloroquine (Oral) Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: Global: Hydroxychloroquine (Oral) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: Global: Hydroxychloroquine (Intravenous) Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: Global: Hydroxychloroquine (Intravenous) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: North America: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: North America: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: United States: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: United States: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: Canada: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: Canada: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: Asia Pacific: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: Asia Pacific: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: China: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: China: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: Japan: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: Japan: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: India: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: India: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: South Korea: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: South Korea: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: Australia: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: Australia: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: Indonesia: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: Indonesia: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Others: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Others: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Europe: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Europe: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Germany: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Germany: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: France: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: France: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: United Kingdom: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 75: United Kingdom: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 76: Italy: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 77: Italy: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 78: Spain: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 79: Spain: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 80: Russia: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 81: Russia: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 82: Others: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 83: Others: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 84: Latin America: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 85: Latin America: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 86: Brazil: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 87: Brazil: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 88: Mexico: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 89: Mexico: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 90: Others: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 75: Others: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 76: Middle East and Africa: Hydroxychloroquine Market: Sales Value (in Million US$), 2014 & 2019
Figure 77: Middle East and Africa: Hydroxychloroquine Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 78: Global: Hydroxychloroquine Industry: SWOT Analysis
Figure 79: Global: Hydroxychloroquine Industry: Value Chain Analysis
Figure 80: Global: Hydroxychloroquine Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Hydroxychloroquine Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Hydroxychloroquine Market Forecast: Breakup by Dosage Type (in Million US$), 2020-2025
Table 3: Global: Hydroxychloroquine Market Forecast: Breakup by Distribution (in Million US$), 2020-2025
Table 4: Global: Hydroxychloroquine Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 5: Global: Hydroxychloroquine Market Forecast: Breakup by Grade (in Million US$), 2020-2025
Table 6: Global: Hydroxychloroquine Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
Table 7: Global: Hydroxychloroquine Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 8: Global: Hydroxychloroquine Market Structure
Table 9: Global: Hydroxychloroquine Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links